Previous 10 | Next 10 |
CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2021. Second Quarter 2021 Highlights Sales of $255.2 million increased 61.7% year over year as reported and 58.2% in constant currency. Domestic revenue increase...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
The CPI-W increased 6.1% year-over-year in June. Healthcare is historically a strong performer later in the business cycle. The healthcare sector is improving in our large cap sector ranking. Top scoring healthcare stocks worth adding to your watch list. For further deta...
Mikhail Leonov/iStock via Getty Images Positive simufilam data may already be priced into Cassava With the Alzheimer's Association International Conference less than two weeks away, Cantor Fitzgerald is downgrading shares of Alzheimer's player Cassava Sciences ([[SAVA]] -6.6%) from overweight...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2021 after the market close on Wednesday, July 28, 2021. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
The medtech industry could be in the early stages "of another multi-year period out outperformance," according to a new analysis from Barclays.The firm has outlined 8 reasons why it is bullish on the industry: 1) robust innovation; last year's cancelled procedures are likely to return; 3) new...
Our job as #investors is to pay attention to the #stocks we own. Part of that involves looking at the #fundamentals, but half of the disclosure comes from looking at price action. The Conmed (NASDAQ: CNMD) data table below can help you with price action, and we have more d...
When #institutionalinvestors make decisions to buy and sell #stocks they normally want to keep it quiet. However, if we pay close attention we can see what is going on, and make good decisions.. The Conmed (NASDAQ: CNMD) report below can help you understand how to do this....
News, Short Squeeze, Breakout and More Instantly...
Conmed Corp. - Ordinary Shares Company Name:
CNMD Stock Symbol:
NASDAQ Market:
Conmed Corp. - Ordinary Shares Website:
2024-07-18 18:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CONMED Corporation (NYSE: CNMD) today announced it will report financial results for the second quarter of 2024 after the market close on Wednesday, July 31, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participat...
2024-07-08 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...